Eon Labs Inc has received final approval for Tizanidine HCl, 2mg tablets, the generic alternative for the spasticity treatment Zanaflex.
Commenting on the approval, Frank Della Fera, Vice President of Sales and Marketing said, "The 2mg approval rounds out our offerings in the Tizanidine HCl market and provides us with the full range of generics currently available."
Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products.